Cargando…

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas

BACKGROUND: The aim of this study was to compare clinical and pathological outcomes after neoadjuvant chemotherapy between oestrogen receptor (ER)-positive invasive pure lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). METHODS: This analysis included 1895 patients (n=177 ILC; n=1718 IDC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delpech, Y, Coutant, C, Hsu, L, Barranger, E, Iwamoto, T, Barcenas, C H, Hortobagyi, G N, Rouzier, R, Esteva, F J, Pusztai, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566807/ https://www.ncbi.nlm.nih.gov/pubmed/23299541 http://dx.doi.org/10.1038/bjc.2012.557

Ejemplares similares

Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma
por: Delpech, Yann, et al.
Publicado: (2015)

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer
por: Truin, W., et al.
Publicado: (2015)

Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma
por: Timbres, Jasmine, et al.
Publicado: (2021)

Change in Main Histological Type of Invasive Breast Cancer From Ductal to Lobular Carcinoma by Neoadjuvant Chemotherapy
por: Okubo, Takako, et al.
Publicado: (2023)

Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.
por: Lee, A. H., et al.
Publicado: (1996)

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology
por: McCart Reed, Amy E, et al.
Publicado: (2018)

Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis
por: O'Connor, Dómhnall J., et al.
Publicado: (2021)

Neoadjuvant chemotherapy in locally advanced invasive lobular carcinoma: A limited institutional experience
por: Gogia, Ajay, et al.
Publicado: (2018)

The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors
por: Pérez-Mies, Belén, et al.
Publicado: (2022)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
por: Dixon, A. R., et al.
Publicado: (1991)

Collective invasion in ductal and lobular breast cancer associates with distant metastasis
por: Khalil, Antoine A., et al.
Publicado: (2017)

Phylogenetic analysis of combined lobular and ductal carcinoma of the breast
por: Kobayashi, Hiroko, et al.
Publicado: (2021)

PB.04: MRI In lobular and mixed lobular/ductal carcinomas: can we preselect cases based on imaging appearance?
por: Hoosein, MM, et al.
Publicado: (2013)

Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Heitz, Florian, et al.
Publicado: (2019)

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
por: Lee, So Heun, et al.
Publicado: (2023)

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
por: Ring, A E, et al.
Publicado: (2004)

Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responses
por: Natowicz, René, et al.
Publicado: (2008)

Pleomorphic lobular carcinoma: is it more similar to a classic lobular cancer or to a high-grade ductal cancer?
por: Costarelli, Leopoldo, et al.
Publicado: (2017)

Loss of Mammographic Tissue Homeostasis in Invasive Lobular and Ductal Breast Carcinomas vs. Benign Lesions
por: Gerasimova-Chechkina, Evgeniya, et al.
Publicado: (2021)

Histopathological and clonal study of combined lobular and ductal carcinoma of the breast
por: Tazaki, Eri, et al.
Publicado: (2013)

Granulomatous lobular mastitis associated with ductal carcinoma in situ of the breast
por: Oddó, David, et al.
Publicado: (2019)

Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
por: Du, Tian, et al.
Publicado: (2018)

Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.
por: Toikkanen, S., et al.
Publicado: (1997)

Relevance of systems biological approach in the differential diagnosis of invasive lobular carcinoma & invasive ductal carcinoma
por: Ragunath, PK, et al.
Publicado: (2012)

Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
por: Jung, Seung Pil, et al.
Publicado: (2012)

Expression of Sarcosine Metabolism-Related Proteins in Invasive Lobular Carcinoma: Comparison to Invasive Ductal Carcinoma
por: Cha, Yoon Jin, et al.
Publicado: (2015)

Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
por: Adachi, Yayoi, et al.
Publicado: (2016)

Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma
por: Chen, Zheling, et al.
Publicado: (2017)

Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
por: Lobbes, Marc B.I., et al.
Publicado: (2017)

Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study
por: Pu, Ning, et al.
Publicado: (2023)

Classifying invasive lobular carcinoma as special type breast cancer may be reducing its treatment success: A comparison of survival among invasive lobular carcinoma, invasive ductal carcinoma, and no-lobular special type breast cancer
por: Cosar, Rusen, et al.
Publicado: (2023)

Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment
por: Ramalingam, Kirithiga, et al.
Publicado: (2023)

Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma
por: Cha, Yoon Jin, et al.
Publicado: (2017)

Prognosis and Early Diagnosis of Ductal and Lobular Type in Breast Cancer Patient
por: EHTEMAM, Houriyeh, et al.
Publicado: (2017)

Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer
por: Jin, R, et al.
Publicado: (2000)

High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies
por: Bollet, M A, et al.
Publicado: (2008)

Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis
por: Turashvili, Gulisa, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_phief6nsoveg17bk23chl7i56j